Hierarchical pulmonary target nanoparticles via inhaled administration for anticancer drug delivery
Inhalation administration, compared with intravenous administration, significantly enhances chemotherapeutic drug exposure to the lung tissue and may increase the therapeutic effect for pulmonary anticancer. However, further identification of cancer cells after lung deposition of inhaled drugs is ne...
Main Authors: | Rui Chen, Liu Xu, Qin Fan, Man Li, Jingjing Wang, Li Wu, Weidong Li, Jinao Duan, Zhipeng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2017.1365395 |
Similar Items
-
Liposomal Drug Delivery Systems and Anticancer Drugs
by: Temidayo O. B. Olusanya, et al.
Published: (2018-04-01) -
Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel
by: Bing Yan, et al.
Published: (2011-07-01) -
How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs
by: Mariangela Garofalo, et al.
Published: (2020-04-01) -
Design and Synthesis of Doxorubicin Conjugated Gold Nanoparticles as Anticancer Drug Delivery System
by: Xia, Long
Published: (2017) -
Aggregated Nanotransfersomal Dry Powder Inhalation
of Itraconazole for Pulmonary Drug Delivery
by: Mehdi Hassanpour Aghdam, et al.
Published: (2016-03-01)